Synapse - GSK Faculty

Results (22684)

RB1 somatic alterations in ER-positive breast cancer: assessment of neuroendocrine differentiation

Meeting Abstract

Schwartz, C.; Marra, A.; Selenica, P.; da Silva, E. M.; Chandarlapaty, S.; Brogi, E.; Pareja, F.; Wen, H.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Artificial intelligence (AI) image analysis for chromosomal instability (CIN) in primary and metastatic breast cancers (BC)

Meeting Abstract

Oakley, J.; Wang, Y. K.; Klimstra, D.; Pareja, F.; Reis, J.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy (NACT) pathologic response in breast angiosarcoma (AS)

Meeting Abstract

Chang, H. Y.; Dermawan, J.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Epithelioid vascular neoplasms with NFATC1/C2 gene alterations: Expanding the clinicopathologic and molecular characteristics of a distinct entity

Meeting Abstract

Dashti, N.; Perret, R.; Balzer, B.; Michal, M.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Defining novel genomic risk stratification models underlying leiomyosarcoma subtypes

Meeting Abstract

Dermawan, J.; Chiang, S.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Comprehensive genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma

Meeting Abstract

Saoud, C.; Dermawan, J.; Sharma, A.; Wexler, L.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

A comprehensive clinicopathologic and molecular reappraisal of GLI1-altered mesenchymal neoplasms with outcome meta-analysis showing poor survival in GLI1 amplified vs fusion tumors

Meeting Abstract

Saoud, C.; Agaram, N.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

Botryoides-type embryonal rhabdomyosarcoma (ERMS): A clinicopathologic and molecular appraisal of 25 cases across anatomic locations, with emphasis on disparities with its conventional-type counterpart

Meeting Abstract

Sharma, A.; Dermawan, J.; Chiang, S.; Wexler, L.; Antonescu, C.
Laboratory Investigation (2024)

Fulltext@MSK | Save

N/KRAS-mutant AML LSCS originate from committed myelomonocytic progenitors and drive clinical resistance to venetoclax

Meeting Abstract

Sango, J.; Carcamo, S.; Sirenko, M.; Maiti, A.; Mansour, H.; Ulukaya, G.; Tomalin, L.; Olivier, E.; Olszewska, M.; Demircioglu, D.; more...
Experimental Hematology (2024)

Fulltext@MSK | Save

Production of alarmins S100a8/A9 by DNMT3A-mutant hematopoietic cells causes mesenchymal stromal cell senescence and seeds a pro-inflammatory environment in clonal hematopoiesis

Meeting Abstract

Mistry, J.; Young, K.; Maestre, I. F.; Levine, R.; Trowbridge, J.
Experimental Hematology (2024)

Fulltext@MSK | Save